Company Filing History:
Years Active: 2013
Title: Inventor Makoto Mitsunaga: Pioneering Photosensitizing Antibody-Conjugates
Introduction
Makoto Mitsunaga, based in Rockville, MD, is an accomplished inventor known for his significant contributions to the field of biotechnology. His work focuses on developing innovative methods to enhance cancer treatment through advanced therapeutic techniques.
Latest Patents
Mitsunaga holds a noteworthy patent for "Photosensitizing antibody-fluorophore conjugates." This innovative patent pertains to compositions and methods designed to kill cells both in vitro and in vivo. The patent emphasizes a method that involves contacting cells with an antibody-IR700 molecule, which specifically binds to cell surface proteins. Notably, the antibody recognizes tumor-specific antigens on the surface of tumor cells. After binding, cells are irradiated at specific wavelengths, resulting in effective cell destruction. Additionally, the patent introduces wearable devices incorporating an NIR LED, enhancing the practicality of the disclosed methods.
Career Highlights
Mitsunaga is affiliated with the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. His role underscores the intersection of research and public health, reflecting his commitment to advancing medical technologies.
Collaborations
Throughout his career, Mitsunaga has collaborated with notable colleagues, including Hisataka Kobayashi and Peter Choyke. This collaboration highlights the importance of teamwork in driving innovations in biomedical applications.
Conclusion
Makoto Mitsunaga stands out as a forward-thinking inventor whose work in photosensitizing antibody conjugates represents a significant advancement in therapeutic methods. His dedication to improving cancer treatment through innovation and collaboration showcases the potential for future breakthroughs in the medical field.